Autor:	Steven M, Swift, Karen, Sauve, Cara, Cassino, Raymond, Schuch
Rok vydání:	2021
Předmět:	Methicillin-Resistant Staphylococcus aureus Disease Models Animal Mice Staphylococcus aureus Daptomycin Endopeptidases Pneumonia Staphylococcal Animals Pulmonary Surfactants Microbial Sensitivity Tests Staphylococcal Infections Lung Anti-Bacterial Agents
Zdroj:	Antimicrobial agents and chemotherapy. 65(9)
ISSN:	1098-6596
Popis:	Exebacase (CF-301) is a novel antistaphylococcal lysin (cell wall hydrolase) in phase 3 of clinical development for the treatment of Staphylococcus aureus bacteremia, including right-sided endocarditis, used in addition to standard-of-care antibiotics. In the current study, the potential for exebacase to treat S. aureus pneumonia was explored
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::830bd8ff1f30b57bd29e7cb57848315a https://pubmed.ncbi.nlm.nih.gov/34228536 Zobrazit plný text záznamu